Indicia Production has announced the acquisition of Biotechnologie Appliquee, based in Taden, in Cotes-d’Armor, France.
The financial terms of this buyout, completed at the end of February, have not been disclosed.
Biotechnologie Appliquee, with a turnover of EUR 500,000 in 2012 and four employees, provides contract manufacturing of ready-to-use media for microbiological testing to the food-processing, pharmaceutical and cosmetic industries.
The company is smaller and more flexible than Indicia Production with extensive expertise in subcontracting. It primarily provides low-volume manufacturing.
This acquisition therefore complements the range of mass-manufactured products from Indicia Production in Lyon.
Indicia Production can now provide contract services for both high and low volume manufacturing and can also respond to client requirements more quickly.
Indicia plans to secure new clients by expanding and diversifying its product range. The company also aims to draw on Biotechnologie Appliquee’s expertise to develop new products throughout 2013.
Ready-to-use culture media are used in the pharmaceutical industry as well as for microbiological diagnostics in food processing and environmental and water monitoring.
They are made from high-quality raw materials and use dehydrated bases selected in accordance with various standards. They are manufactured using advanced technology and are subject to quality testing by approved microbiologists.
“By joining with Indicia, we are able to expand our client base and offer a wider range of products,” said Jean-Yves Horvais, director of Biotechnologie Appliquee.
Horvais continued, “In return, Indicia brings its mass-manufacturing capacities and structured quality assurance. This will allow us to attract new companies within the industry.”
The acquisition enables Indicia Production to strengthen its position as a European leader in the manufacturing of ready-to-use media for microbiological testing.
Indicia is the first subcontractor to manufacture media pouches. The concept was developed at the site 15 years ago.
Biotechnologie Appliquee provides the newly formed company with a better understanding of the raw materials used in these media.
“With this acquisition, we hope to strengthen our production capacities and our subcontracting qualities for both high and low volume manufacturing,” said Stephane Legastelois, president and CEO of Indicia Production.
This buyout is part of Indicia Production’s growth strategy, which began in 2010, including the acquisition of new technologies to increase capacities for filling and sterilizing company media pouches.
Indicia Production, whose turnover reached EUR 5.1 million in 2012, expects a significant increase in profits over the next five years.
“The contract manufacturing market for microbiological testing and aseptic filling is booming. More industry professionals are now choosing to outsource these services in order to reduce their fixed costs,” said Stephane Legastelois. “They are also showing a keen interest in contract services, which we have just strengthened with this acquisition.”
A department manager is expected to join Indicia Production’s on-site team at Biotechnologie Appliquee, in Taden, in the second quarter of 2013.